Symbol
|
RMAFCV | RMAFFV | RMBGYV | RMBKMV | RMAHIV | OTSRCH | RMAV6V | OYFRCH | OVLRCH | RMA4KV | AAYMTQ | Z0A42Z | RMA9EV | RMALYV | RMBPAV | RMAZ0V | RMBJ8V | RMASDV | RMBQSV | ABKBTQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nom | Callable Multi Defender Vonti | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Worst of Reverse Convertible | Callable Multi Defender Vonti | Worst of Reverse Convertible | Worst of Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible |
Sous-jacent
|
Compagnie Financière Richemont SA / Galderma Group AG / Hermès International S.A. / LVMH Moet Hennessy Louis Vuitton | Alcon / Galderma Group AG / Sandoz Group AG | Alcon / Galderma Group AG / Straumann Hldg. AG | Galderma Group AG / Lonza Group N / Nestlé S.A. / Novartis AG / Roche AG | Estée Lauder Co. Inc. / Galderma Group AG / L'Oréal S.A. / Unilever N.V. | Bachem Hldg. AG / Galderma Group AG / Sandoz Group AG | Compagnie Financière Richemont SA / Galderma Group AG / Givaudan | DOCMORRIS AG / Galderma Group AG | Galderma Group AG / Roche AG / Straumann Hldg. AG | Galderma Group AG / Galenica AG / Tecan Group AG | Bachem Hldg. AG / Galderma Group AG / Straumann Hldg. AG | Galderma Group AG / Lonza Group N / Sandoz Group AG | Douglas Hldg. AG / Galderma Group AG / Unilever N.V. | Compagnie Financière Richemont SA / Galderma Group AG / Swatch Group I | CREDIT SUISSE UBS MERGER / Galderma Group AG / Sonova Hldg. AG | CREDIT SUISSE UBS MERGER / Ems-Chemie Hldg. AG / Galderma Group AG / Novartis AG | CREDIT SUISSE UBS MERGER / Galderma Group AG / Tecan Group AG | Galderma Group AG / Givaudan / Ypsomed Hldg. AG | CREDIT SUISSE UBS MERGER / DOCMORRIS AG / Galderma Group AG | Alcon / Galderma Group AG / Novartis AG / Sandoz Group AG |
Emetteur
|
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Échéance
|
20.10.2025 | 29.06.2026 | 02.02.2026 | 16.05.2025 | 24.02.2026 | 02.03.2026 | 20.03.2026 | 30.09.2025 | 13.03.2026 | 07.04.2026 | 20.03.2026 | 09.10.2025 | 28.09.2026 | 19.10.2026 | 27.04.2026 | 12.10.2026 | 05.05.2026 | 11.05.2026 | 18.05.2026 | 12.11.2026 |
Demande | 84,90 | 99,20 | 98,50 | - | 76,00 | 70,98 | - | 66,13 | 97,51 | 64,30 | 77,83 | - | - | 90,20 | 72,10 | 71,60 | 69,60 | 93,60 | - | 97,35 |
Offre | - | 100,00 | 99,90 | - | - | - | - | - | 98,31 | - | - | - | - | 91,60 | - | - | - | 94,60 | - | 98,15 |